Fagiuoli, Stefano
 Distribuzione geografica
Continente #
NA - Nord America 543
EU - Europa 283
AS - Asia 76
SA - Sud America 7
AF - Africa 3
Totale 912
Nazione #
US - Stati Uniti d'America 538
SE - Svezia 96
DE - Germania 59
CN - Cina 50
IT - Italia 48
IE - Irlanda 25
UA - Ucraina 17
FI - Finlandia 10
GB - Regno Unito 10
FR - Francia 9
TR - Turchia 8
BR - Brasile 7
IN - India 6
BZ - Belize 4
JP - Giappone 4
NL - Olanda 3
CZ - Repubblica Ceca 2
KR - Corea 2
PH - Filippine 2
CH - Svizzera 1
CI - Costa d'Avorio 1
GR - Grecia 1
HK - Hong Kong 1
IL - Israele 1
IR - Iran 1
MX - Messico 1
NG - Nigeria 1
RO - Romania 1
RS - Serbia 1
SG - Singapore 1
TN - Tunisia 1
Totale 912
Città #
Chandler 88
Houston 55
Ashburn 53
Redmond 45
Chicago 27
Dublin 25
Rome 16
Nanjing 15
San Mateo 15
Jacksonville 13
Wilmington 13
New York 11
San Jose 10
Boston 9
Cattolica 9
Dearborn 8
Milan 7
Princeton 7
Helsinki 6
Las Vegas 6
Ann Arbor 5
Izmir 5
Zhengzhou 5
Belize City 4
Lawrence 4
Marseille 4
Seattle 4
Simi Valley 4
Woodbridge 4
Albuquerque 3
Beijing 3
Capelle 3
Changsha 3
Fairfield 3
Nanchang 3
Norwalk 3
Shenyang 3
Tokyo 3
Boardman 2
Cambridge 2
Fremont 2
Hebei 2
Jiaxing 2
Kunming 2
London 2
Los Angeles 2
Mountain View 2
Munich 2
Redwood City 2
Seoul 2
Tianjin 2
Abidjan 1
Andover 1
Augusta 1
Bangalore 1
Bari 1
Bologna 1
Brdo 1
Bremen 1
Brno 1
Buffalo 1
Changchun 1
Gavirate 1
Guangzhou 1
Hangzhou 1
Hefei 1
Jerusalem 1
Jinan 1
Katerini 1
Kocaeli 1
Lagos 1
Lanzhou 1
Mandaluyong City 1
Mexico City 1
Mumbai 1
Nuremberg 1
Orange 1
Perugia 1
Piacenza 1
Pittsburgh 1
Saint Louis 1
Singapore 1
Slough 1
São Paulo 1
University Park 1
Vigevano 1
Walnut 1
Washington 1
Wuhan 1
Zanjan 1
Zurich 1
Totale 570
Nome #
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 202
Gut microbiota in autism and mood disorders 130
Gut microbiota in autism and mood disorders 109
Treatment of genotype-1 hepatitis C recurrence after liver transplant improves survival in both sustained responders and relapsers 88
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis 69
Long-term maintenance of sustained virological response in liver transplant recipients treated for recurrent hepatitis C 67
Can the Rank of Survival Benefit Be Used as a Priority Allocation System in an European Liver Transplant Waiting List? Evidences from an Italian Multicentre Cohort Study 58
On-treatment serum albumin level can guide long-term treatment in patients with cirrhosis and uncomplicated ascites 49
Daclatasvir-based regimens in HCV cirrhosis: experience from the Italian early access program 48
Real life experiences in HCV management in 2018 36
Predicting in-hospital mortality from Coronavirus Disease 2019: A simple validated app for clinical use 36
X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis 32
Balancing Donor and Recipient Risk Factors in Liver Transplantation: The Value of D-MELD With Particular Reference to HCV Recipients 13
Hepatic encephalopathy increases the risk for mortality and hospital readmission in decompensated cirrhotic patients: a prospective multicenter study 10
Totale 947
Categoria #
all - tutte 3.418
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.418


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201913 0 0 0 0 0 0 0 0 0 0 6 7
2019/2020130 39 17 3 6 5 8 11 2 7 3 9 20
2020/2021101 14 6 8 7 6 5 2 5 21 9 14 4
2021/2022105 10 3 3 5 9 5 1 16 5 6 24 18
2022/2023274 29 39 19 28 20 32 9 33 41 10 6 8
2023/2024123 8 34 5 5 10 12 4 37 2 5 1 0
Totale 947